Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Profile
    • Privacy & Cookie Policy
    • Terms of Use
    • Contact Us
    • Advertising
    • Submit Post
    • Latest News
    • Research Reports
    • Press Release
    • Awards▾
      • About the Awards
      • Awards TimeTable
      • Submit Nominations
      • Testimonials
      • Media Room
      • Award Winners
      • FAQ
    • Magazines▾
      • Global Banking & Finance Review Magazine Issue 79
      • Global Banking & Finance Review Magazine Issue 78
      • Global Banking & Finance Review Magazine Issue 77
      • Global Banking & Finance Review Magazine Issue 76
      • Global Banking & Finance Review Magazine Issue 75
      • Global Banking & Finance Review Magazine Issue 73
      • Global Banking & Finance Review Magazine Issue 71
      • Global Banking & Finance Review Magazine Issue 70
      • Global Banking & Finance Review Magazine Issue 69
      • Global Banking & Finance Review Magazine Issue 66
    Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

    Global Banking & Finance Review® is a leading financial portal and online magazine offering News, Analysis, Opinion, Reviews, Interviews & Videos from the world of Banking, Finance, Business, Trading, Technology, Investing, Brokerage, Foreign Exchange, Tax & Legal, Islamic Finance, Asset & Wealth Management.
    Copyright © 2010-2026 GBAF Publications Ltd - All Rights Reserved. | Sitemap | Tags | Developed By eCorpIT

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    Home > Headlines > UK seizes record haul of illegal weight-loss drugs in factory raid
    Headlines

    UK seizes record haul of illegal weight-loss drugs in factory raid

    Published by Global Banking & Finance Review®

    Posted on October 24, 2025

    1 min read

    Last updated: January 21, 2026

    Image of Spirax's manufacturing operations emphasizes the company's optimistic sales growth forecast for the second half of the year, reflecting strong performance in the finance sector.
    Spirax manufacturing facility showcasing growth in UK sales - Global Banking & Finance Review
    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    Tags:innovationhealthcarePublic Healthregulatory frameworksustainability

    Quick Summary

    UK's MHRA dismantled a factory in England, seizing 2,000 illegal weight-loss drug pens, marking the largest global seizure of its kind.

    Table of Contents

    • UK's Record Seizure of Illegal Weight-Loss Drugs
    • Details of the Seizure
    • Health Minister's Statement

    UK Authorities Make Historic Seizure of Illegal Weight-Loss Drugs

    UK's Record Seizure of Illegal Weight-Loss Drugs

    LONDON (Reuters) -Britain's medicines regulator on Friday said it had made the largest single seizure of trafficked weight loss medicines recorded globally, dismantling a factory making thousands of unlicensed weight-loss jabs.

    The Medicines and Healthcare products Regulatory Agency (MHRA) said it had seized 2,000 pens labelled as containing tirzepatide and retatrutide - drugs not approved for weight loss in the UK - tens of thousands of empty pens, and raw chemicals.

    The agency said the factory in central England was the first of its kind discovered in Britain.

    Details of the Seizure

    "This is a victory in the fight against the shameless criminals who are putting lives at risk by peddling dangerous and illegal weight loss jabs to make a quick buck," health minister Wes Streeting said in a statement.

    Health Minister's Statement

    "These unregulated products, made with no regard for safety or quality, posed a major risk to unwitting customers."

    ($1 = 0.7451 pounds)

    (Reporting by Sam Tabahriti; editing by William James)

    Key Takeaways

    • •UK authorities seized a record number of illegal weight-loss drugs.
    • •The factory was producing unlicensed weight-loss jabs.
    • •2,000 pens containing tirzepatide and retatrutide were confiscated.
    • •The MHRA led the operation in central England.
    • •Health Minister Wes Streeting condemned the illegal operations.

    Frequently Asked Questions about UK seizes record haul of illegal weight-loss drugs in factory raid

    1What is the main topic?

    The article discusses the UK's largest seizure of illegal weight-loss drugs from a factory in central England.

    2What drugs were seized?

    Authorities seized pens containing tirzepatide and retatrutide, which are not approved for weight loss in the UK.

    3Who led the operation?

    The Medicines and Healthcare products Regulatory Agency (MHRA) led the operation.

    More from Headlines

    Explore more articles in the Headlines category

    Image for Two airports in Poland closed due to Russian strikes on Ukraine
    Two airports in Poland closed due to Russian strikes on Ukraine
    Image for Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Exclusive-US plans initial payment towards billions owed to UN-envoy Waltz
    Image for Trump says good talks ongoing on Ukraine
    Trump says good talks ongoing on Ukraine
    Image for France to rally aid for Lebanon as it warns truce gains remain fragile
    France to rally aid for Lebanon as it warns truce gains remain fragile
    Image for Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Exclusive-US aims for March peace deal in Ukraine, quick elections, sources say
    Image for Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Ukraine's Zelenskiy calls for faster action on air defence, repairs to grid
    Image for Olympics-Italy's president takes the tram in video tribute to Milan transport
    Olympics-Italy's president takes the tram in video tribute to Milan transport
    Image for Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Goldman Sachs teams up with Anthropic to automate banking tasks with AI agents, CNBC reports
    Image for Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market
    Image for Big Tech's quarter in four charts: AI splurge and cloud growth
    Big Tech's quarter in four charts: AI splurge and cloud growth
    Image for Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Exclusive-Bangladesh PM front-runner rejects unity government offer, says his party set to win
    Image for Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    Azerbaijan issues strong protest to Russia over lawmaker's comments on Karabakh trial
    View All Headlines Posts
    Previous Headlines PostUK industry body finds AstraZeneca in breach of code over Symbicort marketing
    Next Headlines PostRussian envoy to meet Witkoff in United States, media reports say